Proteomics

Dataset Information

0

Quantitative Proteomic Analysis of Pancreatic Cyst Fluid Proteins Associated with Malignancy in Intraductal Papillary Mucinous Neoplasms


ABSTRACT: Intraductal papillary mucinous neoplasm (IPMN) is a benign tumor that grows within the pancreatic ducts characterized by the production of thick mucinous fluid by surrounding tumor cells. IPMN is the most important precursor lesion for pancreatic cancer that is the fourth most common cause of cancer deaths. Differentiating between low-grade dysplasia (LGD), high-grade dysplasia (HGD), and invasive intraductal papillary mucinous neoplasms (IPMNs) remains a diagnostic challenge with current biomarkers, necessitating the development of novel biomarkers that can distinguish IPMN malignancy. We investigated differentially expressed proteins among pancreatic cyst fluids consisted of LGD, HGD, and invasive IPMN patients by using our novel proteomic strategy, and finally we discovered pancreatic cyst fluid protein marker candidates that can predict the malignant potential of IPMNs.

INSTRUMENT(S): Q Exactive

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Cyst

DISEASE(S): Pancreatic Intraductal Papillary-mucinous Neoplasm

SUBMITTER: Misol Do  

LAB HEAD: Youngsoo Kim

PROVIDER: PXD008302 | Pride | 2018-05-01

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
MaxQuant_Output.zip Other
PCfluid_Indv_HGD_2nd_14S037279_TR1.raw Raw
PCfluid_Indv_HGD_2nd_14S037279_TR2.raw Raw
PCfluid_Indv_HGD_2nd_14S037279_TR3.raw Raw
PCfluid_Indv_HGD_2nd_19303866_TR1.raw Raw
Items per page:
1 - 5 of 48
altmetric image

Publications

Glycomic and proteomic profiling of pancreatic cyst fluids identifies hyperfucosylated lactosamines on the N-linked glycans of overexpressed glycoproteins.

Mann Benjamin F BF   Goetz John A JA   House Michael G MG   Schmidt C Max CM   Novotny Milos V MV  

Molecular & cellular proteomics : MCP 20120305 7


Pancreatic cancer is now the fourth leading cause of cancer deaths in the United States, and it is associated with an alarmingly low 5-year survival rate of 5%. However, a patient's prognosis is considerably improved when the malignant lesions are identified at an early stage of the disease and removed by surgical resection. Unfortunately, the absence of a practical screening strategy and clinical diagnostic test for identifying premalignant lesions within the pancreas often prevents early detec  ...[more]

Similar Datasets

2020-09-06 | PXD016127 | Pride
2010-12-23 | E-GEOD-19650 | biostudies-arrayexpress
2023-06-07 | GSE233293 | GEO
2017-08-22 | PXD005671 | Pride
2011-05-18 | E-GEOD-29352 | biostudies-arrayexpress
2010-12-23 | GSE19650 | GEO
2011-05-18 | GSE29352 | GEO
2022-03-22 | GSE169618 | GEO
2022-03-22 | GSE153548 | GEO
2011-12-01 | E-GEOD-26647 | biostudies-arrayexpress